Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (15081)	2/14/1998 4:57:00 PM
From: tonyt	Read Replies (5) \| Respond to of 32384

"It always amazes me that people can get excited about rat data since it is not really predictive of how a drug will work in humans," said analyst Charles Engelberg.

To: Andrew H who wrote (15081)	2/14/1998 5:26:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Andy, I never ceases to amaze me how a poster, who is always looking for something negative to say about a company, but really has never said anything about a company's science or technology (open up his mouth to remove all doubt) can first bold comments Message 3414254 from an analysts who few have ever head of, and then when that point is made, repost the same quote, leaving off the firm's name to try to give the quote a bit more substance. <<"It always amazes me that people can get excited about rat data since it is not really predictive of how a drug will work in humans," said Americal Securities analyst Charles Engelberg.>> I realize that not too many know who Americal Securities is, so when quoting, couldn't the poster at least give the firm a plug. I think that they could use the exposure. So far it's LGND 4 (Bear Stearns, Robertson Stephens, Lehman Brothers, and Hambrecht & Quits), RATS 1 (Americal Securities).